Clinical Trial Update: Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing quemliclustat plus chemotherapy versus placebo plus chemotherapy in metastatic pancreatic ductal adenocarcinoma is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Quemliclustat (Quemliclustat)

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING